The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog ran from 2006 to 2016 and was intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Recent Posts

  • Recent Comments

    CAM use among cancer patients during drug trials

    A key outcome of early cancer drug studies is the toxicity of a new experimental drug. The use of CAM in patients with advanced cancer might make it difficult to make this determination.

    Researchers at The University of Texas MD Anderson Cancer Center, in Houston, studied the prevalence of CAM use in their patients participating in experimental cancer drug treatment studies.

    First the details.

    • 404 patients in a phase 1 treatment clinic were surveyed for their use of CAM drugs.
    • Nonpharmacologic CAM included prayer, meditation, hypnosis, massage, and acupuncture.

    And, the results.

    • 52% used at least 1 CAM.
    • Among CAM users…
      • 77% used pharmacologic CAM
      • 71% used nonpharmacologic CAM
      • 48% used both
    • The most frequent CAM used were…
      • Vitamins (70%)
      • Prayer (57%)
      • Herbal products (26%)
    • CAM use
      • CAM use was not significantly associated with race, age, level of education, employment, or income level.
      • Women used CAM significantly than men.
    • There was no statistically significant association between the use of CAM and quality of life as perceived by patients.
    • Among the CAM users…
      • 43% had been using CAM for longer than 5 years.
      • Only 5% reported having side effects from using CAM
      • 23% did not fully disclose their CAM use to their physicians.

    The bottom line?

    The authors concluded, “CAM usage is common in patients with advanced malignancies seen in a phase 1 clinic.”

    These findings have significant implications for researchers and pharmaceutical companies as they screen for new drugs in cancer therapy.

    5/8/11 21:05 JR

    Comments are closed.